US Patent 9,169,483
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US)
The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence that encodes poly-glutamine repeat diseases, and methods of using these RNAi molecules.
Davidson, Beverly L.; Mas Monteys, Alejandro; and Boudreau, Ryan L. RNA interference suppression of neurodegenerative diseases and methods of use thereof. US Patent 9,169,483 filed July 02, 2013 and issued October 27, 2015. https://ir.uiowa.edu/patents/646